Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
2012
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer
2006
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 Standout
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Tumorigenesis in mice carrying a truncating Brca1 mutation
2001
The Role of KRAS Mutation Testing in the Management of Patients With Metastatic Colorectal Cancer
2009
In search of the tumour-suppressor functions of BRCA1 and BRCA2
2000 Nature
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
Global trends in emerging infectious diseases
2008 StandoutNature
Cell cycle checkpoint signaling through the ATM and ATR kinases
2001 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Autophagy in mammalian development and differentiation
2010 Standout
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
2006
The Von Hippel-Lindau Protein Interacts with Heteronuclear Ribonucleoprotein A2 and Regulates Its Expression
2001
Cellular Senescence in Cancer and Aging
2007 Standout
The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression
2005
Identification of BRCA1-IRIS, a BRCA1 locus product
2004
Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
2004
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
2003 StandoutNobel
Oncogenic K-ras Stimulates Wnt Signaling in Colon Cancer Through Inhibition of GSK-3β
2005
Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains
2002
Ubiquitin Ligase Activity of TFIIH and the Transcriptional Response to DNA Damage
2005 StandoutNobel
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Cancer genes and the pathways they control
2004 Standout
Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein
2003
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform
2003
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status
1999
Human Claspin Is a Ring-shaped DNA-binding Protein with High Affinity to Branched DNA Structures
2004 StandoutNobel
Loss of Expression of a 55 kDa Nuclear Protein (nmt55) in Estrogen Receptor-Negative Human Breast Cancer
1997
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
Methods in Mammalian Autophagy Research
2010 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis
2002
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
Eicosanoids and cancer
2010 Standout
MicroRNA signatures in human cancers
2006 Standout
Computationally Designed Armadillo Repeat Proteins for Modular Peptide Recognition
2016 StandoutNobel
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Genomic instability — an evolving hallmark of cancer
2010 Standout
The Hallmarks of Aging
2013 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
DNA‐Templated Organic Synthesis: Nature's Strategy for Controlling Chemical Reactivity Applied to Synthetic Molecules
2004 Standout
The role of the ubiquitin/proteasome system in cellular responses to radiation
2003
Cancer as an evolutionary and ecological process
2006 Standout
Mitochondria and cancer
2012 Standout
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing
2005
Understanding eukaryotic linear motifs and their role in cell signaling and regulation
2008
Direct DNA binding by Brca1
2001
Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC–mTOR signaling pathways
2006
KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection
2009
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
2004 StandoutNobel
High sequence fidelity in a non-enzymatic DNA autoligation reaction
1999
von Hippel-Lindau Disease
2006 StandoutNobel
Targeted inactivation of p53 in human cells does not result in aneuploidy.
2002
Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
2002
Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
1998
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
RING Domain E3 Ubiquitin Ligases
2009 Standout
RNA-Binding Proteins Tia-1 and Tiar Link the Phosphorylation of Eif-2α to the Assembly of Mammalian Stress Granules
1999 Standout
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
1997
Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence
2001
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
Constitutive Expression of AID Leads to Tumorigenesis
2003 StandoutNobel
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
2003 StandoutNobel
DNA Double-Strand Breaks
2002 StandoutNobel
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Efficient and Rapid Template-Directed Nucleic Acid Copying Using 2′-Amino-2′,3′-dideoxyribonucleoside−5′-Phosphorimidazolide Monomers
2009 StandoutNobel
Sporadic Epithelial Ovarian Cancer: Clinical Relevance of BRCA1 Inhibition in the DNA Damage and Repair Pathway
2008
Heterogeneous Nuclear Ribonucleoprotein A2 Is a Common Transcriptional Coactivator in the Nuclear Transcription Response to Mitochondrial Respiratory Stress
2009
Mechanisms of Alternative Pre-Messenger RNA Splicing
2003 Standout
The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer.
2005
The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.
2009
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Frank Scott being referenced
Purification and Characterization of a Protein That Permits Early Detection of Lung Cancer
1996
Expression in human lung cancer cell lines of genes of prohormone processing and the neuroendocine phenotype
1996
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
2000
Detection of K-rasOncogene Mutations by Polymerase Chain Reaction-Based Ligase Chain Reaction
1996
High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.
1997
Induction of gastrin releasing peptide by all-trans retinoic acid in small cell lung cancer cells.
1998
K-ras Point Mutation Detection in Lung Cancer: Comparison of Two Approaches to Somatic Mutation Detection Using ARMS Allele-specific Amplification
2000
Evidence of torovirus infection in diarrhoeic cattle
1996
Telomerase activity in non-small cell lung carcinomas correlates with smoking status.
1999